Cargando…
In Silico Prediction and Prioritization of Novel Selective Antimicrobial Drug Targets in Escherichia coli
Novel antimicrobials interfering with pathogen-specific targets can minimize the risk of perturbations of the gut microbiota (dysbiosis) during therapy. We employed an in silico approach to identify essential proteins in Escherichia coli that are either absent or have low sequence identity in seven...
Autores principales: | Svanberg Frisinger, Frida, Jana, Bimal, Donadio, Stefano, Guardabassi, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229198/ https://www.ncbi.nlm.nih.gov/pubmed/34070637 http://dx.doi.org/10.3390/antibiotics10060632 |
Ejemplares similares
-
LptD depletion disrupts morphological homeostasis and upregulates carbohydrate metabolism in Escherichia coli
por: Frisinger, Frida Svanberg, et al.
Publicado: (2023) -
Impact of the Gram-Negative-Selective Inhibitor MAC13243 on In Vitro Simulated Gut Microbiota
por: Svanberg Frisinger, Frida, et al.
Publicado: (2022) -
DNA Damage Repair and Drug Efflux as Potential Targets for Reversing Low or Intermediate Ciprofloxacin Resistance in E. coli K-12
por: Klitgaard, Rasmus N., et al.
Publicado: (2018) -
Antimicrobial synergy between carprofen and doxycycline against methicillin-resistant Staphylococcus pseudintermedius ST71
por: Brochmann, Rikke Prejh, et al.
Publicado: (2016) -
Antimicrobial resistance in clinical Escherichia coli isolates from poultry and livestock, China
por: Yassin, Afrah Kamal, et al.
Publicado: (2017)